Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Koenig

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Trials|November 21, 2018
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine AgencyOlivier Collignon, Franz Koenig, Armin Koch, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2005
IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammationJürgen Reisinger, Andrea Triendl, Ernst Küchler, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Neuro-Oncology Practice|March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.
Clinical Pharmacology and Therapeutics|October 2, 2019
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent ValidationHans-Georg Eichler, Franz Koenig, Peter Arlett, et al.
Journal of Hepatology|October 10, 2022
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and consJuan M Pericàs, Frank Tacke, Quentin M Anstee, et al.
Frontiers in Medicine|October 31, 2025
A model structure for describing uncertainties in benefit-risk assessment of oncology drug applicationsNikolaos Zafiropoulos, Francesco Pignatti, Andreas Kouroumalis, et al.
BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.
Infection|July 21, 2021
Correction to: COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, AustriaErich Pawelka, Mario Karolyi, Theresa Mader, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Trials|November 21, 2018
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine AgencyOlivier Collignon, Franz Koenig, Armin Koch, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2005
IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammationJürgen Reisinger, Andrea Triendl, Ernst Küchler, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Neuro-Oncology Practice|March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.
Clinical Pharmacology and Therapeutics|October 2, 2019
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent ValidationHans-Georg Eichler, Franz Koenig, Peter Arlett, et al.
Journal of Hepatology|October 10, 2022
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and consJuan M Pericàs, Frank Tacke, Quentin M Anstee, et al.
Frontiers in Medicine|October 31, 2025
A model structure for describing uncertainties in benefit-risk assessment of oncology drug applicationsNikolaos Zafiropoulos, Francesco Pignatti, Andreas Kouroumalis, et al.
BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.
Infection|July 21, 2021
Correction to: COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, AustriaErich Pawelka, Mario Karolyi, Theresa Mader, et al.
Pageof 7